These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3028860)

  • 1. [Effect of trapidil and papaverine on thrombocyte aggregation and phosphodiesterase activity].
    Glusa E
    Farmakol Toksikol; 1986; 49(6):48-9. PubMed ID: 3028860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative effect of chlorpromazine, imipramine and papaverine on the blood platelet function].
    Bartel' V; Gluza E; Markvardt F
    Farmakol Toksikol; 1976; 39(3):296-301. PubMed ID: 193725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
    Mazurov AV; Leĭtin VL; Repin VS
    Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of aspirin, molsidomine, trapidil, and some trapidil derivatives on arachidonic acid induced reversible thrombocyte aggregation in the rabbit.
    Zehl U; Mest HJ; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S381-4. PubMed ID: 6440554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
    Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
    Asano T; Ochiai Y; Hidaka H
    Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by isochinoline derivatives.
    Markwardt F
    Acta Univ Carol Med Monogr; 1972; 52():79-82. PubMed ID: 4361263
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic activity and the mechanism of action of trapidil (Rocornal).
    Suzuki Y; Yamaguchi K; Shimada S; Kitamura Y; Ohnishi H
    Prostaglandins Leukot Med; 1982 Dec; 9(6):685-95. PubMed ID: 6296885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytosolic Ca++ mobilization in human platelets by the antianginal drug trapidil and its derivative AR 12463.
    Block HU; Gabbasov ZA; Pozin EY; Popov EG; Mest HJ
    Biomed Biochim Acta; 1988; 47(12):1093-7. PubMed ID: 2855396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of trapidil on prostacyclin formation by rabbit heart tissue].
    Geling NG; Kudriashov SA
    Biull Eksp Biol Med; 1982 Aug; 94(8):48-50. PubMed ID: 6751431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
    Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
    FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
    Losonczy H; Nagy I; Gregus Z
    Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of MK-447 on platelet shape change, aggregation, and ATP release by collagen, ADP, and stable analogue of thromboxane A2 in rabbit platelets.
    Li BY; Zhou H; Qiao GF; Wang L; Li WH
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):627-30. PubMed ID: 10678127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological properties of trapidil: comparison with other coronary vasodilators (author's transl)].
    Ohnishi H; Kosuzume H; Yamaguchi K; Sato M; Umehara S; Funato H; Itoh C; Suzuki K; Kitamura Y; Suzuki Y; Itoh R
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):495-503. PubMed ID: 7009345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
    Lakin KM; Makarow WA; Mular AG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil.
    Tiell ML; Sussman II; Gordon PB; Saunders RN
    Artery; 1983; 12(1):33-50. PubMed ID: 6678578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.